UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023841
Receipt number R000027358
Scientific Title Analysis of the perinatal biochemichal and physiological factors associated with long-term neurodevelopmental outcomes in monochorionic twins
Date of disclosure of the study information 2016/09/01
Last modified on 2019/09/04 11:47:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analysis of the perinatal biochemichal and physiological factors associated with long-term neurodevelopmental outcomes in monochorionic twins

Acronym

Monochorionic twins Developmental Outcome Study(MonDO Study)

Scientific Title

Analysis of the perinatal biochemichal and physiological factors associated with long-term neurodevelopmental outcomes in monochorionic twins

Scientific Title:Acronym

Monochorionic twins Developmental Outcome Study(MonDO Study)

Region

Japan


Condition

Condition

monochorionic twins

Classification by specialty

Obstetrics and Gynecology Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To analyze the perinatal biochemical and physiological factors associated with long-term neurodevelopmental outcomes in monochorionic twins

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Predictive factors of death or morbidity of severe neurological sequelae(cerebral palsy,blindness and hearing loss) at 18 and 36 months of age

Key secondary outcomes

Factors associated with growth retardation,mild neurodevelopmental delay,epilepsy,cardiac problems and renal problems at 18 and 36 months of age


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

3 years-old >=

Gender

Male and Female

Key inclusion criteria

MD twin infants and children whose mothers received antenatal care at Toho University Ohmori Medical Center

Agree to participate in the study

Key exclusion criteria

Not agree to participate in the study

Those that the reserchers were considered inappropriate

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Hitoshi
Middle name
Last name Yoda

Organization

Toho University Ohmori Medical Center

Division name

Neonatology

Zip code

143-8541

Address

6-11-1,Ohmori-Nishi,Ohta-ku,Tokyo 143-8541,Japan

TEL

03-3762-4151

Email

yoda@med.toho-u.ac.jp


Public contact

Name of contact person

1st name Hiroko
Middle name
Last name Arai

Organization

Toho University Ohmori Medical Center

Division name

Neonatology

Zip code

143-8541

Address

6-11-1,Ohmori-Nishi,Ohta-ku,Tokyo 143-8541,Japan

TEL

03-3762-4151

Homepage URL


Email

araihiro@med.toho-u.ac.jp


Sponsor or person

Institute

Toho University Ohmori Medical Center

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education,Culture,Sports,Science and Tecnology of Japan

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Toho University Omori Medical Center

Address

6-11-1,Omori-Nishi,Ota-ku,Tokyo,

Tel

03-3762-4151

Email

somu.omori@jim.toho-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2016 Year 07 Month 29 Day

Date of IRB

2016 Year 07 Month 13 Day

Anticipated trial start date

2016 Year 08 Month 01 Day

Last follow-up date

2022 Year 09 Month 30 Day

Date of closure to data entry

2022 Year 09 Month 30 Day

Date trial data considered complete

2022 Year 09 Month 30 Day

Date analysis concluded

2023 Year 03 Month 31 Day


Other

Other related information

In outborn cases,we will ask for survey of MD twin's outcome.


Management information

Registered date

2016 Year 08 Month 30 Day

Last modified on

2019 Year 09 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027358


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name